Metabolic

GLP-3（Retatrutide）

Retatrutide (LY3437943) is a novel triple-agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. This triple mechanism produces synergistic metabolic effects beyond single or dual agonists. Phase 2 clinical trials have demonstrated significant results ...

size

Pack

Quantity

$49.99

Bundle & Save

CoA

Mon – Fri delivery

Overnight shipping available

We accept

Free shippingon orders over $150

Damageprotection

Secure checkout256-bit SSL

Certificate of Analysis

Third Party Tested

ISO/IEC 17025 Accredited

Latest ISO 17025 7× Testing Selected dosage

99.67%

Purity

✓ Passed full QC panel

VariantGLP-3（Retatrutide） 500mg

Lot #SAMPLE001

Labeled500mg

Actual532.29mg

TestedMay 29, 2026

Full QC Panel 7× tested

Purity (HPLC)99.67%

Net Peptide Content532.29mg

Identity (HPLC)GLP-3（Retatrutide）

HPLC Conformitymean 99.62%

Heavy Metals (ICP-MS)Not Detected

Sterility (PCR)No Growth

Endotoxin (USP <85>)0.052 EU/mL

ISO/IEC 17025 Accredited

Compound Information

Chemical and structural properties

Molecular Profile

GLP-3（Retatrutide） Structure

Essential dinucleotide coenzyme

Coenzyme Endogenous

CAS Number53-84-9

Molecular FormulaC21H27N7O14P2

Molecular Weight663.43 g/mol

TypeDinucleotide coenzyme

ComponentsNicotinamide + Adenine + Ribose + Phosphate

Biological Targets

Enzyme Interactions

Essential cofactor for multiple enzyme families

SirtuinsSIRT1-7 deacetylases

PARPsDNA repair enzymes

CD38/CD157NAD+ glycohydrolases

Oxidoreductases500+ enzymes

Physical Properties

Handling & Storage

Stability and storage requirements

AppearanceWhite to off-white powder

SolubilityFreely soluble in water

Storage (powder)-20°C, protected from light

Solution stabilityUse promptly, refrigerate

Sources & References

Peer-reviewed research

Frontiers in Endocrinology

Association of Human Whole Blood NAD+ Contents With Aging

2022 DOI: 10.3389/fendo.2022.829658 • PMID: 35370948

Yang F, et al.

View Source

Trends in Cell Biology

NAD+ and Sirtuins in Aging and Disease

2014 PMID: 24786309

Imai S, Guarente L

View Source

Antioxidants

A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+

2019 PMID: 31508207

Grant R, et al.

View Source

Circulation

NAD+ Metabolism in Cardiac Health, Aging, and Disease

2021 PMID: 34843394

Abdellatif M, et al.

View Source

Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

All the research peptides you need, with the peace of mind and research community at your fingertips.

Shop Now

GLP-3（Retatrutide）

Certificate of Analysis

GLP-3（Retatrutide） Structure

Enzyme Interactions

Handling & Storage

Association of Human Whole Blood NAD+ Contents With Aging

NAD+ and Sirtuins in Aging and Disease

A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+

NAD+ Metabolism in Cardiac Health, Aging, and Disease

⚠️ Important Research Notice

All the research peptides you need, with the peace of mind and research community at your fingertips.

Research updates from Amino Club

Important Research Notice